Manufacturing Department of Health’s nominated vaccines (likely Novavax) within 4 months then no CR for short term.
If IDT needs a new facility for mRNA vaccine then a CR would be required - estimated total cost for greenfield facilities is $250m
Ann: Supplementary Disclosure - Sterile Readiness Agreement, page-56
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.010(7.69%) |
Mkt cap ! $51.58M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 11.5¢ | $76.96K | 649.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23275 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 19228 | 1 |
View Market Depth
| Last trade - 15.59pm 05/11/2024 (20 minute delay) ? |
| IDT (ASX) Chart |